Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells

Cancer Biomarkers

Volumn 16, Issue 3, 2016, Pages 445-452

  Ni, Zhenhua ^a   Chen, Qingge ^a   Lai, Yiming ^a   Wang, Ziyuan ^a   Sun, Li ^a   Luo, Xuming ^a   Wang, Xiongbiao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CLPTM1L; invasion; Lung cancer; migration; prognosis

Indexed keywords

CLEFT LIP AND PALATE TRANSMEMBRANE PROTEIN 1 LIKE PROTEIN; GELATINASE A; PROTEIN; UNCLASSIFIED DRUG; CLPTM1L PROTEIN, HUMAN; MEMBRANE PROTEIN; MMP2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KAPLAN MEIER METHOD; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE MICROARRAY; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84964200258     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-160583     Document Type: Article

References (28)

1. J. McKay, R. Hung, V. Gaborieau, P. Boffetta, A. Chabrier and G. Byrnes, Lung cancer susceptibility locus at 5p15.33. Nat Genet 40 (2008), 1404-1406
2. Y. Wang, P. Broderick, E. Webb, X. Wu, J. Vijayakrishnan, A. Matakidou, M. Qureshi, Q. Dong, X. Gu, W.V. Chen, M.R. Spitz, T. Eisen, C.I. Amos and R.S. Houlston, Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40 (2008), 1407-9
3. S. Zienolddiny, V. Skaug, N.E. Landvik, D. Ryberg, D.H. Phillips, R. Houlston and A. Haugen, The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung, Carcinogenesis 30 (2009), 1368-71
4. C. Liu, Y. Wang, H. Huang, C. Wang, H. Zhang, Y. Kong and H. Zhang, Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population, Tumour Biol (2014
5. X. Yang, B. Yang, B. Li and Y. Liu, Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-Analysis including 45, 184 subjects, Arch Dermatol Res 305 (2013), 49-52
6. Y. Zhao, G. Chen, X. Song, H. Chen, Y. Mao and D. Lu, Fine-mapping of a region of chromosome 5p15.33 (TERTCLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population. Int J Cancer 131 (2012), 1569-76
7. K. Yamamoto, A. Okamoto, S. Isonishi, K. Ochiai and Y.Ohtake, A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 280 (2001), 1148-54
8. M.A. James, W. Wen, Y. Wang, L.A. Byers, J.V. Heymach, K.R. Coombes, L. Girard, J. Minna and M. You, Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS One 7 (2012), e36116
9. Z. Ni, K. Tao, G. Chen, Q. Chen, J. Tang, X. Luo, P. Yin and X. Wang, CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS One 7 (2012), e52598
10. M.A. James, H.G. Vikis, E. Tate, A.L. Rymaszewski and M. You, CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. Cancer Res 74 (2014), 1116-27
11. J. Jia, A.D. Bosley, A. Thompson, J.W. Hoskins, A. Cheuk, I. Collins, H. Parikh, Z. Xiao, K. Ylaya, M. Dzyadyk, W. Cozen, B.Y. Hernandez, C.F. Lynch, J. Loncarek, S.F. Altekruse, L. Zhang, C.J. Westlake, V.M. Factor, S. Thorgeirsson, W.R. Bamlet, S.M. Hewitt, G.M. Petersen, T. Andresson and L.T. Amundadottir, CLPTM1L Promotes Growth and Enhances Aneuploidy in Pancreatic Cancer Cells. Cancer Res 74 (2014), 2785-95
12. S.O. Yoon, S.J. Park, C.H. Yun and A.S. Chung, Roles of matrix metalloproteinases in tumor metastasis and angiogenesis, J Biochem Mol Biol 36 (2003), 128-37
13. I. Marecko, D. Cvejic, S. Tatic, V. Dragutinovic, I. Paunovic and S. Savin, Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma. Cancer Biomark 11 (2011), 49-58
14. A.K. Karam, C. Santiskulvong, M. Fekete, S. Zabih, C. Eng and O. Dorigo, Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression, Cytoskeleton (Hoboken) 67 (2010), 535-44
15. M. Bjorklund and E. Koivunen, Gelatinase-mediated migration and invasion of cancer cells, Biochim Biophys Acta 1755 (2005), 37-69
16. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent and A. Jemal, Global cancer statistics, 2012, CA Cancer J Clin 65 (2015), 87-108
17. E. Lou, M. Johnson, C. Sima, R. Gonzalez-Espinoza, M. Fleisher, M.G. Kris and C.G. Azzoli, Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer. Cancer Biomark 14 (2014), 207-14
18. S. Subramaniam, R.K. Thakur, V.K. Yadav, R. Nanda, S. Chowdhury and A. Agrawal, Lung cancer biomarkers: State of the art, J Carcinog 12 (2013), 3
19. M. Lando, M. Holden, L.C. Bergersen, D.H. Svendsrud, T. Stokke, K. Sundfor, I.K. Glad, G.B. Kristensen and H. Lyng, Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer, PLoS Genet 5 (2009), e1000719
20. O. Vazquez-Mena, I. Medina-Martinez, E. Juarez-Torres, V. Barron, A. Espinosa, N. Villegas-Sepulveda, L. Gomez-Laguna, K. Nieto-Martinez, L. Orozco, E. Roman-Basaure, S. Munoz Cortez, M. Borges Ibanez, C. Venegas-Vega, M. Guardado-Estrada, A. Rangel-Lopez, S. Kofman and J. Berumen. Am.plified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines. PLoS One 7 (2012), e32667
21. R. Zhang, X. Chen, S. Zhang, X. Zhang, T. Li, Z. Liu, J. Wang, W. Zang, Y.Wang, Y. Du and G. Zhao, Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma, Dig Dis Sci 60 (2015), 1247-55
22. H. Lee, J.S. Kim and E. Kim, Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways. PLoS One 7 (2012), e50624
23. Y.C. Lee, H.H. Lin, C.H. Hsu, C.J. Wang, T.A. Chiang and J.H. Chen, Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway, Eur J Pharmacol 632 (2010), 23-32
24. J.M. Tang, Q.Y. He, R.X. Guo and X.J. Chang, Phosphorylated Akt overexpression and loss of PTEN expression in nonsmall cell lung cancer confers poor prognosis, Lung Cancer 51 (2006), 181-91
25. J.K. Park, S.H. Park, K. So, I.H. Bae, Y.D. Yoo and H.D. Um, ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol 36 (2010), 181-92
26. S. Shukla, G.T. Maclennan, D.J. Hartman, P. Fu, M.I. Resnick and S. Gupta, Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121 (2007), 1424-32
27. L. Derycke, C. Stove, A.S. Vercoutter-Edouart, O. De Wever, L. Dolle, N. Colpaert, H. Depypere, J.C. Michalski and M. Bracke, The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells. Int J Dev Biol 55 (2011), 835-40
28. J.C. Sandquist, K.I. Swenson, K.A. Demali, K. Burridge and A.R. Means, Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A and B during cell rounding and migration, J Biol Chem 281 (2006), 35873-83